Atrial fibrillation is a heart rhythm disorder which develops through abnormal electrical signals that affect the heart's upper chambers. Some people experience early symptoms while others live with the condition for many years without realising it. AFib serves as a leading stroke risk factor and a primary reason for hospital admissions, worldwide.
The causes of AFib are high blood pressure, heart disease, diabetes, sleep disorders or long-term stress. Clinical research is currently in progress to understand these risks, enhance early diagnosis and test new therapies while monitoring measures are under investigation to support earlier diagnosis and improved long-term care.
Interested in learning more about participation in our clinical research studies? Determine your eligibility by responding to a brief set of inquiries. By completing the form below, you grant us permission to connect with you via phone, text, or email, offering further details through our research team.
If these health challenges disrupt your daily routine, you might be eligible for a clinical research opportunity. Feel free to reach out by filling out the form provided or giving us a call. Once you've submitted, one of our specialized team members at Biopharma will promptly get in touch with you.